End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-01 | Soleno Therapeutics, Inc.(NasdaqCM:SLNO) added to Russell 3000E Index | CI |
07-01 | Soleno Therapeutics, Inc.(NasdaqCM:SLNO) added to Russell 3000 Growth Index | CI |
Sales 2024 * | - | Sales 2025 * | 44.75M 60.95M | Capitalization | 1.53B 2.08B |
---|---|---|---|---|---|
Net income 2024 * | -96M -131M | Net income 2025 * | -78M -106M | EV / Sales 2024 * | - |
Net cash position 2024 * | 238M 324M | Net cash position 2025 * | 151M 206M | EV / Sales 2025 * | 30.8 x |
P/E ratio 2024 * |
-16.6
x | P/E ratio 2025 * |
-23.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.61% |
Latest transcript on Capnia Inc
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 19-11-13 |
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Bill Harris
BRD | Director/Board Member | 65 | 14-06-01 |
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+17.44% | 25.93B | |
-24.33% | 19.27B | |
-19.49% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |